15 results
8-K
EX-1.1
MBRX
Moleculin Biotech Inc
25 Jun 21
Entry into a Material Definitive Agreement
5:22pm
8-K
EX-1.1
MBRX
Moleculin Biotech Inc
4 Feb 21
Moleculin Announces Proposed Underwritten Public Offering
4:07pm
SC 13G
EX-1
MBRX
Moleculin Biotech Inc
13 Nov 20
Moleculin Biotech / Lincoln Park Capital Fund ownership change
6:01am
8-K
EX-1.1
MBRX
Moleculin Biotech Inc
17 Jul 20
Entry into a Material Definitive Agreement
5:19pm
8-K
EX-1.1
MBRX
Moleculin Biotech Inc
17 Mar 20
Moleculin Signs Agreement with UTMB to Test WP1122 on a Range of Viruses, including Coronavirus
7:31am
8-K
EX-1.1
8pywxsd ega7tmkwo20
6 Feb 20
Entry into a Material Definitive Agreement
9:06am
8-K
EX-1.1
jhtma
24 Jul 19
Entry into a Material Definitive Agreement
7:30am
8-K
EX-1.1
qaxn389lw inkd2p5v
23 Apr 19
Moleculin Announces $15.0 Million Registered Direct Offering
9:34pm
8-K
EX-1.1
ddytb426 mk
28 Mar 19
Moleculin Announces Proposed Underwritten Public Offering
6:18am
8-K
EX-1.1
5caew qbqk
21 Jun 18
Entry into a Material Definitive Agreement
4:36pm
8-K
EX-1.1
vmic5
16 Feb 18
Entry into a Material Definitive Agreement
12:00am
8-K
EX-1.1
z2jt15 vr
15 Sep 17
Entry into a Material Definitive Agreement
12:00am
8-K
EX-1.1
pjrsgjneg2gag sja
9 Feb 17
Moleculin Announces Pricing of $5 Million Underwritten Public Offering
12:00am
- Prev
- 1
- Next